FGF and FGF receptors in normal and pathological hematopoiesis;Les FGF et leurs recepteurs dans l'hematopoiese normale et pathologique

Hematologie

Volumn 4, Issue 5, 1998, Pages 361-369

  Popovici, Cornel ^a   Ollendorff, Vincent ^a   Coulier, Francois ^a   Pébusque, Marie Josèphe ^a   Birnbaum, Daniel ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR;

APOPTOSIS; CELL PROLIFERATION; CHROMOSOME 13Q; CHROMOSOME 14Q; CHROMOSOME 4P; CHROMOSOME 6Q; CHROMOSOME 8P; CHROMOSOME 9Q; CHROMOSOME TRANSLOCATION; ENZYME ACTIVITY; HEMATOPOIESIS; HUMAN; MULTIPLE MYELOMA; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION;

EID: 0031772479     PISSN: 12647527     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Burdine RD, Chen ED, Kwok SF, Stern MJ. Egl-17 encodes an invertebrate fibroblast growth factor family member required specifically for sex myoblast migration in Caenorhabditis elegans. Proc Natl Acad Sci USA 1997 ; 94 : 2433-7.
2. Sutherland D, Samakovlis C, Krasnow M. Branchless encodes a drosophila FGF homolog that controls tracheal cell migration and the pattern of branching. Cell 1996; 87: 1091-101.
3. Coulier F, Pontarotti P, Roubin R, Hartung H, Goldfarb M, Birnbaum D. Of worms and men : an evolutionary perspective of the fibroblast growth factor (FGF) and FGF receptor families. J Mol Evol 1997 ; 44 : 43-50.
4. Smallwood PM, Munoz-Sanjuan I, Tong P, Macke JP, Hendry SHC, Gilbert DJ, Copeland NG, Jenkins NA, Nathans J. Fibroblast growth factor (FGF) homologous factors : new members of the FGF family implicated in nervous system development. Proc Natl Acad Sci USA 1996 ; 93: 9850-7.
5. Miyake A, Konishi M, Martin F, Hernday N, Ozaki K, Yamamoto S, Mikami T, Arakawa T, ltoh N. Structure and expression of a novel member, FGF-16, of the fibroblast growth factor family. Biochem Biophys Res Comm 1998, 243 : 148-52.
6. McWhirter JR, Goulding M, Weiner JA, Chun J, Murre C. A novel fibroblast growth factor gene expressed in the developing nervous system is a downstream target of the chimeric homeodomain oncoprotein E2A-Pbx1. Development 1997; 124: 3221-32.
7. Hoshikawa M, Ohbayashi N, Yonamine A, Konishi M, Ozaki K, Fukui S, ltoh N. Structure and expression of a novel fibroblast growth factor, FGF-17, preferentially expressed in the embryonic brain. Biochem Biophys Res Comm 1998; 244. 187-91.
8. Johnson DE, Williams LT. Structural and func-tional diversity in the FGF multigene family. Adv Concer Res 1993; 60: 1-41.
9. Shishido E, Higashijima SI, Emori Y, Saigo K. Two FGF-receptor homologues of drosophila : one is expressed in mesodermal primordium in early embryos. Development 1993 ; 117 : 751-61.
10. Beiman M, Shilo BZ, Volk T. Heartless, a drosophila FGF receptor homolog, is essential for cell migration and establishment of several mesodermal lineages. Genes Develop 1996 ; 10: 2993-3002.
11. DeVore D, Horvitz H, Stern M. An FGF-receptor signaling pathway is required for the normal cell migration of the sex myoblasts in C. elegans hermaphrodites. Cell 1995 ; 82 : 611-20.
12. Goldfarb M. Functions of fibroblast growth factors in vertebrate development. Cytokine Growth Factor Rev 1996; 7: 311-25.
13. Brunner G, Nguyen H, Gabrilove J, Rifkin DB, Wilson EL. Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells. Blood 1993 ; 81 : 631-8.
14. + hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia, Blood 1996; 88: 4534-46
15. Berardi AC, Wang A, Abraham J, Scadden DT. Basic fibroblast growth factor mediates its effects on committed myeloid progenitors by direct action and has no effect on hematopoiefic stem cells. Blood 1995; 86: 2123-9.
16. Bikfalvi A, Han ZC, Fuhrmann G. Interaction of fibroblast growth factor (FGF) with megakaryocytopoiesis and demonstration of FGF receptor expression in megakaryocytes and megakaryocytic-like cells. Blood 1992; 80: 1905-13.
17. Testa U, Fossati C, Samoggia P, Masciulli R, Mariani G, Hassan HJ, Sposi NM, Guerriero R, Rosato V, Gabbianelli M, Pelosi E, Valtieri M, Peschle C. Expression of growth factor receptors in unilineage differentiation culture of purified hematopoietic progenitors. Blood 1996; 88: 3391-406.
18. Oliver LJ, Rifkin DB, Gabrilove J, Hannocks MJ, Wilson EL. Long-term culture of human bone marrow stromal cells in the presence of basic fibroblast growth factor. Growth Factors 1990; 3 : 231-6.
19. Quito FL, Beh J, Bashayan O, Basilica C, Basch RS. Effects of fibroblast growth factor-4 (k-FGF) on long-term cultures of human bone marrow cells. Blood 1996 ; 87 : 1282-91.
20. Keller JR, Mcniece IK, Sill KT, Ellingsworth LR, Quesenberry PJ, Sing GK, Ruscetti FW. Transforming growth factor β directly regulates primitive murine hematopoietic cell proliferation. Blood 1990; 75 : 596-602.
21. Gabbianelli M, Sargiacomo M, Pelosi E, Testa U, lsacchi G, Peschle C. «Pure » human hematopoietic progenitors . permissive action of basic fibroblast growth factor. Science 1990 ; 249: 1561-4.
22. Gabrilove JL, White K, Rahman Z, Wilson EL. Stem cell factor and basic fibroblast growth factor are synergistic in augmenting commited myeloid progenitor cell growth. Blood 1994; 83 : 907-10.
23. Gabrilove JL, Wong G, Bollenbacher E, White K, Kojima S, Wilson EL. Basic fibroblast growth factor counteract the suppressive effect of transforming growth factor β1 on human myeloid progenitor cells. Blood 1993; 81 : 909-15.
24. Fafeur V, Terman BI, Blum J, Böhlen P. Basic FGF treatment of endothelial cells down-regulates the 85-kDa TGFβ receptor subtype and decreases the growth inhibitory response to [GFβ] Growth Factors 1990 ; 3: 237-45.
25. Wilson EL, Rifkin DB, Kelly F, Hannocks MJ, Gabrilove JL. Basic fibroblast growth factor stimulates myelopoiesis in long-term human bone marrow cultures. Blood 1991 ; 77: 954-60.
26. Gallicchio VS, Hughes NK, Hulette BC, DellaPuca R, Noblitt L. Basic fibroblast growth factor (b-FGF) induces early-(CFU-s) and late-stage hematopoietic progenitor cell colony formation (CFU-gm, CFU-meg, and BFU-e) by synergizing with GM-CSF, Meg-CSF, and erythropoietin, and is a radioprotective agent in vivo. Int J Cell Cloning 1991; 9: 220-32.
27. Aglietta M, Stacchini A, Severino A, Sanavio F, Ferrando ML, Piacibello W. Interaction of transforming growth factor β1 with hemopoietic growth factors in the regulation of human normal and leukemic myelopoiesis. Exp Hematol 1989; 17: 296-9.
28. Burger PE, Dowdle EB, Lukey PT, Wilson EL. Basic fibroblast growth factor antagonizes transforming growth factor β-mediated erythroid differentiation in K562 cells. Blood 1994; 7: 1 808-1 2
29. Sakamoto H, Ochiya T, Sato Y, Tsukamoto M, Konishi H, Saito I, Sugimura T, Terada M, Adenovirus-mediated transfer of the HST-1 (FGF4) gene induces increased levels of platelet count in vivo. Proc Natl Acad Sci USA 1994, 91 : 12368-72.
30. Matsumoto-Yoshitomi S, Seko C, Kuroshima K, Naruo K, Shino A, Kondo T, Kurokawa T. Stimulation of thrombopoiesis in mice by fibroblast growth factor 9. Growth factors 1995; 12: 176-90.
31. Allouche M, Bikfalvi A. The role of fibroblast growth factor-2 (FGF-2) in hematopoiesis. Prog Growth Factor Res 1995 ; 6 : 35-48.
32. Bikfalvi A, Zhong CH. Angiogenic factors are hematopoietic growth factors and vice versa Leukemia 1994; 8: 523-9.
33. Park JR. Cytokine regulation of apoptosis in hematopoietic precursor cells. Curr Opin Hematol 1996; 3 : 191-6.
34. Fuks Z, Persaud RS, Alfieri A, McLoughlin M, Ehleiter D, Schwartz JL, Seddon AP, Cordon-Cardo C, Haimovitz-Friedman A. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res 1994 ; 54: 2582-90.
35. Chow R, Diez Roux G, Roghani M, Palmer M, Rifkin D, Moscatelli D, Long R. FGF suppresses apoptosis and induces differentiation of fibre cells in the mouse lens. Development 1995; 121 : 4383-93
36. Legeai-Mallet L, Benoist-Lasselin C, Delezoide AL, Munnich A, Bonaventure J. Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondocyte proliferation in thanatophoric dysplasia. J Biol Chem 1998; 273 : 13007-14.
37. Menzel T, Rahman Z, Calleja E, White EL, Wilson EL, Wieder R, Gabrilove J. Elevated intracellular level of basic fibroblast growth factor correlates with stage of chronic lymphocytic leukemia and is associated with resistance to fludarabine. Blood 1996; 87 : 1056-63.
38. König A, Menzel T, Lynen S, Wrazel L, Rosen A, AI-Katib A, Raveche E, Gabrilove JL. Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosis. Leukemia 1997; 11 : 258-65.
39. Allouche M, Bayard F, Clamens S, Fiolla G, Sié P, Amalric F. Expression of fibroblast growth factor (bFGF) and FGF-receptors in human leukemic cells. Leukemia 1995; 9: 77-86.
40. Ding I, Wu T, Matsubara H, Magae J, Shou M, Cook J, Okunieff P. Acidic fibroblast growth factor (FGF 1) increases survival and haematopoietic recovery in total body irradiated C3H/HeNCr mice. Cytokine 1997; 9 : 5945.
41. Martyré MC, Le Bousse-Kerdilès MC, Romquin N, Chevillard S, Praloran V, Demory JL, Dupriez B. Elevated levels of basic fibroblast growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis Br J Haematol 1997; 97: 441-8.
42. Wehmeier A, Südhoff T. Elevated plasma levels of basic fibroblast growth factor in patients with essential thrombocytaemia and polycytaemia vera. Br J Haematol 1997 ; 98 : 1050-1.
43. Cuevas P, de Paz V, Cuevas B, MarinMartinez J, Picon-Molina M, Fernandez-PereiraA, Gimenez-Gallego G. Osteopromotion for cranioplasty' an experimental study in rats using acidic fibroblast growth factor. Surg Neurol 1997; 47 242-6.
44. Martin I, Muraglia A, Campanile G, Cancedda R, Quarto R. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow Endocrinology 1997; 138 : 4456-62.
45. Chesi M, Nardini E, Brents LA, Schrock E, Ried T, Kuehl WM, Bergsagel PL. Frequent translocation t(4; 14)(p 16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet 1997; 16 : 260-4.
46. Richelda R, Ronchetti D, Baldini L, Cro L, Viggiano L, Marzella R, Rocchi M, Otsuki T, Lombardi L, Maiolo AT, Neri A. A novel chromosomal translocation t(4; 14)(p 16.3;q32) in multiple myeloma involves the fibroblast growthfactor receptor 3 gene, Blood 1997 ; 90 : 4062-70.
47. Webster MK, D'Avis PY, Roberfson SC, Donoghue DJ. Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for lethal skeletal dysplasia, thanatophoric dysplasia type II. Mol Cell Biol 1996; 16 : 4081-7.
48. Webster MK, Donoghue DJ. Enhanced signaling and morphological transformation by a membrane-localized derivative of the fibroblast growth factor receptor 3 kinase domain. Mol Cell Biol 1997 ; 17 5739-47.
49. Macdonald D, Aguiar RCT, Goldman JM, Cross NCP. A new myeloproliferative disorder associated with chromosomal translocations involving 8p11 : a review, Leukemia 1995; 9: 1628-30
50. Chaffanet M, Popovici C, Leroux D, Jacrot M, Adelaide J, Dastugue N, Gregoire MJ, Hagemeijer A, Lafage-Pochitaloff M, Birnbaum D, Pebusque MJ. t(6;8), t(8;9) and t(8;13) translocations associated with stem cell myeloproliferative disorders have close or identical breakpoints in chromosome region SpIl-12. Oncogene 1998 ; 16 : 945-9.
51. Popovici C, Adélaïde J, Ollendorff V, Chaffanet M, Guasch G, Jacrot M, Leroux D, Birnbaum D, Pébusque MJ. Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13). Proc Natl Acad Sci USA 1998; 95: 5712-7.
52. Xiao S, Nalabolu SR, Aster JC, Ma J, Abruzzo L, Jaffe ES, Stone R, Weissman SM, Hudson TJ, Flefcher JA. FGFRI is fused with a novel zinc-finger gene, ZNF198, in the t(8; 13) leukaemia/lymphoma syndrome. Nat Genet 1998; 18 : 84-7.
53. Smedley D, Hamoudi R, Clark J, Warren W, Abdul-Rauf M, Somers G, Venter D, Fagan K, Cooper C, Shiptey J. The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP. Hum Mol Genet 1998 ; 7 : 637-42.
54. Still I, Cowell J. The t(8;13) atypical myeloproliferative disorder : further analysis of the ZNF198 gene and lack of evidence for multiple gene disrupted on chromosome 13. Blood 1998; 92 : 1456-7.
55. Reiter A, Sohal J, Kulkarni S, Chase A, Macdonald D, Aguiar R, Conçalves C, Hernandez J, Jennings B, Goldman J, Cross N. Consistent fusion of ZNF198 to the fibroblast growth factor-1 in the t(8; 13)(p11,q12) myeloproliferative syndrome. Blood 1998; 92 : 1735-42.
56. Golub TR, Barker GF, Lovett M, Gilliland DG. Fusion of PDGF receptor βto a novel ets-like gene, tel, in chronic myelomonccytic leukemia with t(5; 12) chromosomal translocation. Cell 1994; 77 : 307-16.
57. Coroll M, Tomasson MH, Barker GF, Golub TR, Gilliland DG. The TEL/platelet-derived growth factor β receptor (PDGFβR) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGFβR kinase-dependent signaling pathways. Proc Natl Acad Sci USA 1996 ; 93 : 14845-50.
58. Sozzi G, Bongarzone I, Miozzo M, Borrello MG, Butti MG, Pilotti S, Della Porta G, Pierotti MA. A t(10; 17) translocation creates the RET/PTC2 chimeric transforming sequence in papillary thyroid carcinoma. Genes Chrom Cancer 1994; 9 : 244-50.
59. Turhan A. Translocation bcr-abl : données biologiques. Hématologie 1995; 1 : 123-31.
60. Lacronique V, Boureux A, Della Volle V, Poirel H, Tran Quang C, Mauchauffé M, Berthou C, Lessard M, Berger R, Ghysdael J, Bernard OA. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science 1997; 278: 1309-12.
61. Peeters P, Raynaud SD, Cools J, Wiodarska I, Grosgeorge J, Philip P, Monpoux F, van Rompaey L, Baens M, van den Berghe H, Marynen P, Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9; 12) in a lymphoid and t(9; 15; 12) in a myeloid leukemia. Blood 1997; 90: 2535-40.
62. Wang JK, Gao G, Goldfarb M. Fibroblast growth factor receptors have different signaling and mitogenic potentials. Mol Cell Biol 1994; 14: 181-8.
63. Osborne BA. Apoptosis and the maintenance of homeostasis in the immune system. Curr Opin immunol 1996 ; 8 : 245-54.
64. Cambier N, Chopra R, Strasser A, Metcalf D, Elefanty AG. BCR-ABL activates pathways mediating cytokine independence and protection against apoptosis in murine hematopoietic cells in a dose-dependent manner. Oncogene 1998; 16 : 335-48.
65. Armstrong E, Vainikka S, Partanen J, Korhonen J, Alitalo R. Expression of fibroblast growth factor receptors in human leukemia cells. Cancer Res 1992 : 52 : 2004-7.